Among these immune-associated ligands and receptors, CTLA4, CCR5 and CSF1R could contribute to tumor immune suppression20–22, while TNFRSF1B and type II IFNR are associated with stimulation in neutrophils23,24. This evidence concerns the gene CCR5 and neoplasm.